Quest for the right Drug

|
עמוד הבית / קונג'ופרי 2.5 מ"ג / מידע מעלון לרופא

קונג'ופרי 2.5 מ"ג CONJUPRI 2.5 MG (LEVAMLODIPINE AS MALEATE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

פומי : PER OS

צורת מינון:

טבליה : TABLETS

Overdose : מינון יתר

11     OVERDOSAGE

Overdosage might be expected to cause excessive peripheral vasodilation with marked hypotension and possibly a reflex tachycardia. In humans, experience with intentional overdosage of amlodipine is limited.
Single oral doses of amlodipine equivalent to 40 mg amlodipine/kg and 100 mg amlodipine/kg in mice and rats, respectively, caused deaths. Single oral amlodipine doses equivalent to 4 or more mg amlodipine/kg or higher in dogs (11 or more times the maximum recommended human dose on a mg/m² basis) caused a marked peripheral vasodilation and hypotension.

If massive overdose should occur, initiate active cardiac and respiratory monitoring. Frequent blood pressure measurements are essential. Should hypotension occur, provide cardiovascular support including elevation of the extremities and the judicious administration of fluids. If hypotension remains unresponsive to these conservative measures, consider administration of vasopressors (such as phenylephrine) with attention to circulating volume and urine output. As amlodipine is highly protein bound, hemodialysis is not likely to be of benefit.

12   DESCRIPTION

The active ingredient levamlodipine maleate is the maleate salt of levamlodipine, the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker.

Levamlodipine maleate is chemically described as (S)3-ethyl-5-methyl-2-(2- aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate maleate, and its structural formula is:



Levamlodipine maleate is an off-white to light yellow crystalline powder with a molecular weight of 524.95. It is slightly soluble in water and sparingly soluble in ethanol. CONJUPRI (levamlodipine) tablets are formulated as white to off-white tablets containing 2.5, and 5 mg of levamlodipine (equivalent to 3.2, and 6.4 mg of levamlodipine maleate respectively), for oral administration. In addition to the active ingredient, levamlodipine maleate, each tablet contains the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, betadex, colloidal silicon dioxide, magnesium stearate.

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

OFEK PHARMA LTD, ISRAEL

רישום

176 44 37508 99

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

17.09.24 - עלון לרופא

עלון מידע לצרכן

17.09.24 - עלון לצרכן אנגלית 17.09.24 - עלון לצרכן עברית 17.09.24 - עלון לצרכן ערבית

לתרופה במאגר משרד הבריאות

קונג'ופרי 2.5 מ"ג

קישורים נוספים

RxList WebMD Drugs.com